BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 27420743)

  • 1. Hypereosinophilia Progressing to Granulocytic Sarcoma and Acute Myelocytic Leukemia with Trisomy 8: A Case Report and Review of the Literature.
    Lynott A; Ravandi-Kashani F; Giles FJ
    Hematology; 1999; 4(6):487-93. PubMed ID: 27420743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignancy: Case Report: Hypereosinophilia Progressing to Granulocytic Sarcoma and Acute Myelocytic Leukemia with Trisomy 8: A Case Report and Review of the Literature.
    Lynott A; Ravandi-Kashani F; Giles FJ
    Hematology; 2000; 4(6):487-493. PubMed ID: 11399591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilic leukaemias and the idiopathic hypereosinophilic syndrome.
    Bain BJ
    Br J Haematol; 1996 Oct; 95(1):2-9. PubMed ID: 8857931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management.
    Gotlib J
    Am J Hematol; 2015 Nov; 90(11):1077-89. PubMed ID: 26486351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.
    Gotlib J
    Am J Hematol; 2014 Mar; 89(3):325-37. PubMed ID: 24577808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. World Health Organization-defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management.
    Gotlib J
    Am J Hematol; 2012 Sep; 87(9):903-14. PubMed ID: 22926771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management.
    Gotlib J
    Am J Hematol; 2011 Aug; 86(8):677-88. PubMed ID: 21761433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does hypereosinophilic syndrome precede common B acute lymphoblastic leukaemia in childhood? A case report.
    Ayhan AC; Timur C; Ayhan Y; Cakır B; Erguven M
    Acta Haematol; 2012; 127(2):90-2. PubMed ID: 22156491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multilineage involvement in hypereosinophilic syndrome terminating in granulocytic sarcoma and leukaemic transformation with trisomy 8.
    Fujii N; Ikeda K; Takahashi N; Kojima K; Kobayashi Y; Ashiba A; Takenaka K; Fukuda S; Shinagawa K; Ishimaru F; Niiya K; Miura I; Tanimoto M; Harada M
    Br J Haematol; 2002 Dec; 119(3):716-9. PubMed ID: 12437650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity.
    Valent P; Degenfeld-Schonburg L; Sadovnik I; Horny HP; Arock M; Simon HU; Reiter A; Bochner BS
    Semin Immunopathol; 2021 Jun; 43(3):423-438. PubMed ID: 34052871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia.
    Cilloni D; Messa F; Martinelli G; Gottardi E; Arruga F; Defilippi I; Carturan S; Messa E; Fava M; Giugliano E; Rosso V; Catalano R; Merante S; Nicoli P; Rondoni M; Ottaviani E; Soverini S; Tiribelli M; Pane F; Baccarani M; Saglio G
    Leukemia; 2007 Jul; 21(7):1442-50. PubMed ID: 17508006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexplained hypereosinophilia and the need for cytogenetic and molecular genetic analyses.
    Smith KJ; Jacobson E; Hamza S; Skelton H
    Arch Dermatol; 2004 May; 140(5):584-8. PubMed ID: 15148104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic eosinophilic leukemia with complex karyotypic abnormalities including trisomy 8].
    Wakabayashi S; Yamamoto K; Arai A; Miura O
    Rinsho Ketsueki; 2008 Jul; 49(7):510-5. PubMed ID: 18709984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypereosinophilic syndromes.
    Roufosse FE; Goldman M; Cogan E
    Orphanet J Rare Dis; 2007 Sep; 2():37. PubMed ID: 17848188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Diagnostic Work-Up of Hypereosinophilia.
    Wang SA
    Pathobiology; 2019; 86(1):39-52. PubMed ID: 29961056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophilic disorders: molecular pathogenesis, new classification, and modern therapy.
    Gotlib J; Cross NC; Gilliland DG
    Best Pract Res Clin Haematol; 2006; 19(3):535-69. PubMed ID: 16781488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
    Bernell P; Jacobsson B; Nordgren A; Hast R
    Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case of chronic eosinophilic leukemia with deletion of chromosome 16 and hepatitis C.
    Kamineni P; Baptiste A; Hassan M; Dawkins FW; Zaidi S; Tefferi A; Lindsey M; Taddesse-Heath L
    J Natl Med Assoc; 2006 Aug; 98(8):1356-60. PubMed ID: 16916138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Spectrum of Hypereosinophilia and Associated Clonal Disorders - A Real-World Data Based on Combined Retrospective and Prospective Analysis from a Tropical Setting.
    Sreedharanunni S; Varma N; Sachdeva MUS; Naseem S; Malhotra P; Bansal D; Trehan A; Varma S
    Mediterr J Hematol Infect Dis; 2018; 10(1):e2018052. PubMed ID: 30210745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.